Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

• Prif Awduron: Tangui Barré (Awdur), Fabrice Carrat (Awdur), Clémence Ramier (Awdur), Hélène Fontaine (Awdur), Vincent Di Beo (Awdur), Morgane Bureau (Awdur), Céline Dorival (Awdur), Dominique Larrey (Awdur), Elisabeth Delarocque-Astagneau (Awdur), Philippe Mathurin (Awdur), Fabienne Marcellin (Awdur), Ventzislava Petrov-Sanchez (Awdur), Carole Cagnot (Awdur), Patrizia Carrieri (Awdur), Stanislas Pol (Awdur), Camelia Protopopescu (Awdur), the ANRS/AFEF Hepather study group (Awdur)
• Fformat: Llyfr
• Cyhoeddwyd: BMC, 2022-06-01T00:00:00Z.
• Pynciau: article
• Mynediad Ar-lein: Connect to this object online.

Abstract Background Patients with chronic hepatitis C virus (HCV) infection are at greater risk of developing metabolic disorders. Obesity is a major risk factor for these disorders, and therefore, managing body weight is crucial. Cannabis use, which is common in these patients, has been associated...